RENAISSANCE TECHNOLOGIES LLC
Institutional investor · Portfolio as of Q3 2019
Top Holdings3,394 positions
BRISTOL-MYERS SQUIBB CO | 32.8M | $1.7B | 1.4% | $38.44 | 0.00% | 1 qtr | First report 0 |
CHIPOTLE MEXICAN GRILL INC | 1.9M | $1.6B | 1.4% | $16.81 | 0.00% | 1 qtr | First report 0 |
VERISIGN INC | 8.3M | $1.6B | 1.3% | $185.27 | 0.00% | 1 qtr | First report 0 |
CELGENE CORP | 15.5M | $1.5B | 1.3% | — | — | 1 qtr | First report 0 |
NOVO-NORDISK A S | 24.8M | $1.3B | 1.1% | $22.12 | 0.00% | 1 qtr | First report 0 |
PALO ALTO NETWORKS INC | 5.8M | $1.2B | 1.0% | $33.97 | 0.00% | 1 qtr | First report 0 |
BIOGEN INC | 4.2M | $982.8M | 0.8% | $232.82 | 0.00% | 1 qtr | First report 0 |
VERTEX PHARMACEUTICALS INC | 5.8M | $982.5M | 0.8% | $169.42 | 0.00% | 1 qtr | First report 0 |
GILEAD SCIENCES INC | 14.7M | $933.9M | 0.8% | $48.92 | 0.00% | 1 qtr | First report 0 |
META PLATFORMS INC | 4.9M | $879.8M | 0.7% | $176.39 | 0.00% | 1 qtr | First report 0 |
WALMART INC | 7.3M | $867.9M | 0.7% | $35.96 | 0.00% | 1 qtr | First report 0 |
JOHNSON & JOHNSON | 6.2M | $795.7M | 0.7% | $106.81 | 0.00% | 1 qtr | First report 0 |
STARBUCKS CORP | 8.9M | $784.2M | 0.7% | $75.65 | 0.00% | 1 qtr | First report 0 |
HUMANA INC | 3M | $755.8M | 0.6% | $240.40 | 0.00% | 1 qtr | First report 0 |
| 17.6M | $749.1M | 0.6% | — | — | 1 qtr | First report 0 | |
HERSHEY CO | 4.8M | $748.4M | 0.6% | $131.05 | 0.00% | 1 qtr | First report 0 |
AMGEN INC | 3.7M | $707.9M | 0.6% | $156.61 | 0.00% | 1 qtr | First report 0 |
DUKE ENERGY CORP NEW | 7.3M | $704M | 0.6% | $72.79 | 0.00% | 1 qtr | First report 0 |
| 5.5M | $683.9M | 0.6% | — | — | 1 qtr | First report 0 | |
BP PLC | 17.8M | $676.2M | 0.6% | $26.00 | 0.00% | 1 qtr | First report 0 |
RENAISSANCE TECHNOLOGIES LLC manages $118.1B across 3394 positions as of Q3 2019. Top holdings: BMY (1.4%), CMG (1.4%), VRSN (1.3%). Fund DNA: Diversified Scout. HoldingsIntel Score: 2.5/5.0.
First quarter we have for this fund: 3394 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $118.1B across 3394 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR